Treatment of Secondary Impetigo from Eczematous Fissures
For secondary impetigo arising from an eczematous fissure, treat the bacterial infection with topical mupirocin 2% ointment applied three times daily for 5-7 days while simultaneously managing the underlying eczema with topical corticosteroids and emollients. 1, 2
Dual Treatment Approach Required
This clinical scenario requires addressing both the bacterial superinfection and the underlying inflammatory dermatitis:
Antimicrobial Therapy for Impetiginization
For limited disease (localized to the fissure area):
- Apply mupirocin 2% ointment three times daily for 5-7 days as first-line treatment 1, 2
- Mupirocin is FDA-approved for impetigo caused by Staphylococcus aureus and Streptococcus pyogenes, the most common pathogens in secondary bacterial infections 2, 3
- Topical therapy achieves cure rates 6-fold higher than placebo for limited impetigo 4
Switch to oral antibiotics if:
- No improvement after 3-5 days of topical therapy 1
- Extensive disease beyond the localized fissure area 1
- Systemic symptoms present (fever, lymphangitis) 5
- Multiple scattered lesions develop 1
Oral antibiotic options when needed:
- Cephalexin 250-500 mg four times daily for 7 days (first-line for presumed MSSA) 1, 4
- Dicloxacillin 250 mg four times daily for 7 days (alternative for MSSA) 1, 4
- Clindamycin 300-450 mg three times daily for 7 days if MRSA suspected 1, 4
- Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily for 7 days if MRSA suspected 1, 4
Management of the Underlying Eczematous Fissure
Simultaneously treat the inflammatory component:
- Apply topical corticosteroid (e.g., prednicarbate cream 0.02%) to the eczematous areas to reduce inflammation 5
- Use emollients liberally and frequently to restore the skin barrier 5
- Avoid alcohol-containing lotions; favor oil-in-water creams or ointments 5
Specific fissure management:
- Apply propylene glycol 50% in water for 30 minutes under plastic occlusion nightly, followed by hydrocolloid dressing 5
- Alternatively, use antiseptic baths (potassium permanganate 1:10,000) or topical silver nitrate solutions to accelerate wound closure 5
- Apply emollients to surrounding skin to prevent further fissuring 5
Critical Treatment Considerations
Do NOT use:
- Penicillin alone—it lacks adequate coverage against S. aureus 1, 4
- Topical clindamycin cream—it is FDA-approved only for acne, not impetigo, and has insufficient bioavailability for bacterial skin infections 1
- Bacitracin or neomycin—considerably less effective than mupirocin 1
Important pitfalls to avoid:
- Do not treat the infection without addressing the underlying eczema, as persistent inflammation and barrier dysfunction will predispose to recurrent impetiginization 5
- Topical steroids should only be used under appropriate supervision, as improper use can cause perioral dermatitis and skin atrophy 5
- Ensure 7-day duration for oral antibiotics (not the 5-day course used for topical agents) to prevent treatment failure 1, 4
Infection Control Measures
- Keep lesions covered with clean, dry bandages 1
- Maintain good hand hygiene with regular handwashing 1
- Avoid sharing personal items that contact the skin (towels, clothing) 1
- Exclude from work/school until 24 hours after starting effective antimicrobial therapy 4
When to Obtain Cultures
Consider bacterial culture with antibiotic susceptibility testing if: 5, 1
- Treatment failure after 3-5 days of appropriate therapy
- Recurrent infections
- MRSA suspected based on local epidemiology
- Immunocompromised patient
Special Populations
Penicillin-allergic patients:
- Use clindamycin as preferred alternative 1, 4
- Cephalosporins can be used unless type 1 hypersensitivity (anaphylaxis/hives) to β-lactams 4
Pregnant patients:
- Cephalexin is considered a safe alternative 1
Children under 8 years: